Jay Hoofnagle is director of the Liver Disease Research Branch at the National Institute of Diabetes and Digestive and Kidney Diseases. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.

The bibliographic file:

Dr. Jay Hoofnagle. (2020). Interview with Dr. Jay Hoofnagle on the discovery of hepatitis C and progress in preventing and treating chronic infection.. 2020, de Managing Editor of the Journal Sitio web: https://www.nejm.org/action/showMediaPlayer?doi=10.1056%2FNEJMdo005913&aid=10.1056%2FNEJMp2031110&viewType=Popup&viewClass=Audio&ctype=audiointerview&area=production

Cloth skullcaps mitigate OR contamination more effectively than disposable headgear

A study published online by the Journal of the...

Surgery and scan backlogs set to worsen without government funding, CMA says

As the world enters the second wave of COVID-19,...

Still not enough antibiotics in the works to fight superbugs, WHO says

In a new report shared by Becker’s Hospital...

5 key factors expected to bring the total knee replacement market value to $14.9B by 2030

5 key factors expected to bring the total knee...

National Diabetes Foot Care Report

National Diabetes Foot Care Report The National...

WEBINAR “La evaluación y el manejo de la infección espinal” – Dr. Christopher Kleck

Únase a nosotros mientras presentamos al Dr....

Engineered bacteria could help protect ‘good’ gut microbes from antibiotics

Engineered bacteria could help protect ‘good’...

To fight surgical superbugs, WHO recommends new guidelines

The World Health Organization (WHO) stated that...

Gene-editing produces tenfold increase in superbug slaying antibiotics

ScienceDaily recently featured a study conducted...

Distribuidor exclusivo.

0